Objective: Prognostic parameters in determining risk groups for treatment in neuroblastoma are cellular differentiation, mitosis karyorrhexis index (MKI), N-myc amplification and age. However, additional prognosticators are still needed because patients can show unpredictable biological behavior. We aimed to study the prognostic significance of apoptotic activity in neuroblastomas
BACKGROUND: Current risk stratification systems for neuroblastoma patients consider clinical, histop...
It has been proposed that a lack of apoptosis plays an important role in neuroblastoma (NB) progress...
AIMS: Neuroblastoma is a paediatric solid tumour with a poor outcome except in children <1 year old....
Objective: Prognostic parameters in determining risk groups for treatment in neuroblastoma are cellu...
Multiple defects in apoptotic pathways have been described in peripheral neuroblastic tumours (NTs)....
One of the main challenges in clinical cancer research remains to be accurate outcome prediction at ...
BACKGROUND AND OBJECTIVES: Neuroblastoma is one of the most frequent childhood cancers and a major ...
The prognosis of pediatric neuroblastoma depends both on clinical presentation and on certain cellul...
Background: MYCN status is reported to have a reproducible relationship to mitotic and karyorrhectic...
Neuroblastoma (NB) is one of the most common malignant solid tumors in childhood, which derives from...
Between 1997 and 2003, 47 patients with neuroblastoma were treated at the Mother and Child Health In...
Objective To construct a prognostic model for neuroblastoma (NB) based on cuproptosis-related genes ...
Background MYCN amplification (MYCN-A) is an established adverse prognostic factor in neuroblastoma....
BACKGROUND:MYCN amplification (MYCN-A) is an established adverse prognostic factor in neuroblastoma....
Purpose To select the optimal treatment according to the grade of malignancy of neuroblastoma (NB), ...
BACKGROUND: Current risk stratification systems for neuroblastoma patients consider clinical, histop...
It has been proposed that a lack of apoptosis plays an important role in neuroblastoma (NB) progress...
AIMS: Neuroblastoma is a paediatric solid tumour with a poor outcome except in children <1 year old....
Objective: Prognostic parameters in determining risk groups for treatment in neuroblastoma are cellu...
Multiple defects in apoptotic pathways have been described in peripheral neuroblastic tumours (NTs)....
One of the main challenges in clinical cancer research remains to be accurate outcome prediction at ...
BACKGROUND AND OBJECTIVES: Neuroblastoma is one of the most frequent childhood cancers and a major ...
The prognosis of pediatric neuroblastoma depends both on clinical presentation and on certain cellul...
Background: MYCN status is reported to have a reproducible relationship to mitotic and karyorrhectic...
Neuroblastoma (NB) is one of the most common malignant solid tumors in childhood, which derives from...
Between 1997 and 2003, 47 patients with neuroblastoma were treated at the Mother and Child Health In...
Objective To construct a prognostic model for neuroblastoma (NB) based on cuproptosis-related genes ...
Background MYCN amplification (MYCN-A) is an established adverse prognostic factor in neuroblastoma....
BACKGROUND:MYCN amplification (MYCN-A) is an established adverse prognostic factor in neuroblastoma....
Purpose To select the optimal treatment according to the grade of malignancy of neuroblastoma (NB), ...
BACKGROUND: Current risk stratification systems for neuroblastoma patients consider clinical, histop...
It has been proposed that a lack of apoptosis plays an important role in neuroblastoma (NB) progress...
AIMS: Neuroblastoma is a paediatric solid tumour with a poor outcome except in children <1 year old....